Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1710 results
Microscopic image of an orange stained lung cancer cell dividing into two against a black background.

Researchers have discovered how an immune cell may help lung cancer develop, which could lead to new ways of preventing the disease. Researchers have discovered how an immune cell may help lung cancer develop, which could lead to new ways of preventing the disease.

by Sydney Ghazarian | Analysis | 7 October 2026

7 October 2026

A woman seen from behind preparing for a mammogram. She has long blonde hair tied in a pony tail and is holding a handle on the mammography machine in front of her.

What if all it took to understand your risk of one of the most common types of cancer was a computer program, a spit sample and a questionnaire from your GP? What if all it took to understand your risk of one of the most common types of cancer was a computer program, a spit sample and a questionnaire from your GP?

by Tim Gunn | In depth | 6 October 2026

6 October 2026

A microscopic image of a natural killer cell, a type of immune cell important for protecting against myeloma.

Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma. Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma.

by Elizabeth Kusimo, Tim Gunn | Analysis | 16 September 2026

16 September 2026

A microscope image of cervical cells that have changed shape and size because of HPV infection. Most of the cells are blue, but some are pink or purple.

NHS England will offer HPV self-testing as an option for some 30 to 65-year-olds who are overdue for cervical screening. Read our FAQs for more. NHS England will offer HPV self-testing as an option for some 30 to 65-year-olds who are overdue for cervical screening. Read our FAQs for more.

by Sophie Brooks | In depth, News | 25 August 2026

25 August 2026

Microscopic image of green dendritic cells with blue and red cells against a black background.

Scientists have uncovered how overlooked dendritic cells orchestrate the body's cancer fighting response, which could help improve immunotherapy. Scientists have uncovered how overlooked dendritic cells orchestrate the body's cancer fighting response, which could help improve immunotherapy.

by Sydney Ghazarian | News | 17 August 2026

17 August 2026

clinician wearing giving treatment via tube to patient wearing a white hospital gown

A new international trial is investigating a new drug for ACC, a rare adrenal cancer that has seen little change in treatment for decades. A new international trial is investigating a new drug for ACC, a rare adrenal cancer that has seen little change in treatment for decades.

by Sydney Ghazarian | News | 14 July 2026

14 July 2026

three silver clocks in an open space with people walking passed

A new study suggests that people under the age of 55 may be biologically ageing faster than people who are older. And this trend could be linked to the rise in early-onset cancers. A new study suggests that people under the age of 55 may be biologically ageing faster than people who are older. And this trend could be linked to the rise in early-onset cancers.

by Sydney Ghazarian | Analysis | 30 June 2026

30 June 2026

An image of a radiotherapy machine. Its lights are glowing blue.

Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20.  Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20. 

by Tim Gunn | News | 17 June 2026

17 June 2026

NexTGen team looking at a computer screen in lab

A pioneering trial from Cancer Grand Challenges team NexTGen is testing whether their cutting-edge new therapy can help treat children and young people with solid tumours by harnessing the immune system. A pioneering trial from Cancer Grand Challenges team NexTGen is testing whether their cutting-edge new therapy can help treat children and young people with solid tumours by harnessing the immune system.

by Sophie Wedekind | News | 8 April 2026

8 April 2026